Pharmacy Pearls: Methylphenidate Product ShortagesJanuary 27th, 2023 | Medication Access•Pharmacy Pearls
Reports of Methylphenidate (Concerta®) product shortages have begun to emerge in the marketplace. Patriot, a subsidiary of Janssen and manufacturer of the generic product, will discontinue the generic product at the end of January 2023; however, Janssen will continue to manufacture the brand name, Concerta®. The discontinuation of the generic product is having a negative supply impact on the market and putting pressure on other generic manufacturers. Other oral extended-release forms remain sporadically available. Brand names tend to be available, but cost and coverage remain a challenge for some patients.
Additional Medication Shortage Updates:
- Amoxicillin Suspension product lines seem to be improving as well as their availability at local pharmacies.
- Liquid generic Acetaminophen products are still having supply line issues with intermittent availability.
- Amphetamine Salt products continue to have limited and variable availability, even among pharmacies of the same chain. This is predominantly affecting the Extended Release products.
- GLP-1 Receptor Agonist shortages remain due to increased demand and supply chain issues.